Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Hereditary colorectal cancer syndromes" and "Society guideline links: Colorectal cancer".)
International
●World Gastroenterology Organisation (WGO)/International Digestive Cancer Alliance (IDCA): Practice guidelines for colorectal cancer screening (2007)
Canada
●Canadian Association of Gastroenterology (CAG): Clinical practice guideline on screening for colorectal cancer in individuals with a family history of nonhereditary colorectal cancer or adenoma (2018)
●Choosing Wisely Canada: Don't perform routine colonoscopic surveillance every year in patients following their colon cancer surgery; instead, frequency should be based on the findings of the prior colonoscopy and corresponding guidelines (updated 2017)
●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations on screening for colorectal cancer in primary care (2016)
●Medical Services Commission: British Columbia guidelines for colorectal screening for cancer prevention in asymptomatic patients (2013, revised 2016)
●Choosing Wisely Canada: Avoid colorectal cancer screening tests on asymptomatic patients with a life expectancy of less than 10 years and no family history of colorectal neoplasia (updated 2014)
●CAG: Position statement on screening individuals at average risk for developing colorectal cancer (2010)
United States
●American College of Gastroenterology (ACG): Clinical guidelines on colorectal cancer screening (2021)
●US Preventive Services Task Force (USPSTF): Final recommendation statement on colorectal cancer – Screening (2021)
●United States Multi-Society Task Force (USMSTF) on Colorectal Cancer: Recommendations for follow-up after colonoscopy and polypectomy – A consensus update (2020)
●American College of Physicians (ACP): Screening for colorectal cancer in asymptomatic average-risk adults – A guidance statement (2019)
●American Society of Clinical Oncology (ASCO): Early detection for colorectal cancer resource-stratified guideline (2019)
●Choosing Wisely: Don't obtain routine blood work (eg, CBC, liver function tests) other than a CEA level during surveillance for colorectal cancer (2016, updated 2019)
●American Cancer Society (ACS): Guideline on colorectal cancer screening for average-risk adults, update (2018)
●American College of Radiology (ACR): ACR Appropriateness Criteria colorectal cancer screening (revised 2018)
●Choosing Wisely: Do not repeat colorectal cancer screening (by any method) for 10 years after a high-quality colonoscopy that does not detect neoplasia (2012, updated 2018)
●Cystic Fibrosis Foundation (CFF): Cystic fibrosis colorectal cancer screening consensus recommendations (2018)
●USMSTF on Colorectal Cancer: Consensus guideline for colorectal cancer screening − Recommendations for physicians and patients (2017)
●USMSTF on Colorectal Cancer: Recommendations on fecal immunochemical testing to screen for colorectal neoplasia − A consensus statement (2017)
●USMSTF on Colorectal Cancer: Recommendations for colonoscopy surveillance after colorectal cancer resection (2016)
●ACG: Clinical guideline on genetic testing and management of hereditary gastrointestinal cancer syndromes (2015)
●Choosing Wisely: Don't recommend screening for breast, colorectal, or prostate cancer if life expectancy is estimated to be less than 10 years (2015)
●Choosing Wisely: Don't recommend screening for breast, colorectal, prostate, or lung cancer without considering life expectancy and the risks of testing, overdiagnosis, and overtreatment (2014, revised 2015)
●Choosing Wisely: Only order Methylated Septin 9 (SEPT9) to screen for colon cancer on patients for whom conventional diagnostics are not possible (2013)
●USMSTF on Colorectal Cancer: Guidelines for colonoscopy surveillance after screening and polypectomy − A consensus update (2012)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline for colorectal cancer prevention – Colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease, or adenomas (2011, updated 2022)
●British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/Public Health England (PHE): Post-polypectomy and post-colorectal cancer resection surveillance guidelines (2020)
●BMJ Rapid Recommendations: Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy, or colonoscopy – A clinical practice guideline (2019)
●NICE: Diagnostics guidance on quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (2017)
●NICE: Diagnostics guidance on virtual chromoendoscopy to assess colorectal polyps during colonoscopy (2017)
●Scottish Intercollegiate Guidelines Network (SIGN): Diagnosis and management of colorectal cancer − A national clinical guideline (2011, revised 2016)
Australia-New Zealand
●Australasian Gastrointestinal Pathology Society (AGPS): Consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma (2019)
●Cancer Council Australia (CCA): Clinical practice guidelines for the prevention, early detection, and management of colorectal cancer (2017)
Japan
●[In Japanese] Choosing Wisely Japan: Colonoscopy – When you need it and when you don't (2018)
